Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System (NeoHemoHapt)
Feeding and Eating Disorders
About this trial
This is an interventional treatment trial for Feeding and Eating Disorders focused on measuring preterm infants, high-risk newborns, congenital diaphragmatic hernia, autonomous nervous system, tactile stimulation
Eligibility Criteria
Inclusion Criteria: Preterm birth at gestational age < 30 weeks or Diagnosis of Congenital Diaphragmatic Hernia Born at Amalia Children's Hospital or admitted 1rst day of life Written informed consent of both parents or representatives Exclusion Criteria: Preterm infant born at gestational age ≥ 30 weeks Perinatal Asphyxia; (Apgar score at 5' < 5 and first pH ≤ 7,0) Major congenital anomalies or birth defects other than congenital diaphragmatic hernia; Metabolic disease that necessitates a special diet other than human milk or formula feeding and or has a prognosis of impaired neurological development Parental refusal of participation
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Standard care
Standard care supplemented with HAPTOS intervention
Will receive standard of care according to the institutional protocol and principles of developmental care which currently belongs to (inter-) national guidelines and is regarded as safe.
Will receive standard of care according to the principles of developmental care which currently belongs to (inter-) national guidelines plus HAPTOS intervention which includes: tactile/ kinaesthetic massage of the trunk and extremities twice daily and stimulation of oral function by providing perioral stimulation up to 4 times a day. Interventions will be continued until clinical improvement.